InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Mazar Andrew Paul, Directeur Scientifique. Insider active across 1 companies, notably Monopar Therapeutics. In total, 9 reports have been recorded. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
1,606 shares
Common Stock
SEC:0001654954-22-004490:0·
1,937 shares
Common Stock
SEC:0001654954-22-000130·
1,606 shares
Common Stock
SEC:0001654954-22-000129·
1,606 shares
Common Stock
SEC:0001654954-22-000129:0·
1,937 shares
Common Stock
SEC:0001654954-22-000130:0·
1,606 shares
Common Stock
SEC:0001654954-21-010720·
1,606 shares
Common Stock
SEC:0001654954-21-010720:0·
3,212 shares
Common Stock
SEC:0001654954-21-007595·
3,212 shares
Common Stock
SEC:0001654954-21-007595:0·
9 of 9 declarations
About Mazar Andrew Paul
Mazar Andrew Paul is the Chief Scientific Officer at Monopar Therapeutics. He oversees the company's research and development programs, ensuring innovation and product quality. His role is crucial for the success of the organization's scientific initiatives.
